| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/03/2009 | WO2009052600A3 Extract of aleurites sp., process for obtaining the same and uses thereof |
| 12/03/2009 | WO2009019499A3 Improvements relating to skin dressings |
| 12/03/2009 | WO2008132439A3 Precipitation stabilising compositions |
| 12/03/2009 | WO2008131217A8 Ultrasound imaging with targeted microbubbles |
| 12/03/2009 | WO2008131057A3 Sustained release formulations of opioid and nonopioid analgesics |
| 12/03/2009 | WO2008131056A3 Sustained release monoeximic formulations of opioid and nonopioid analgesics |
| 12/03/2009 | WO2008086971A9 β-LACTAM-CONTAINING FORMULATIONS HAVING INCREASED STABILITY IN AQUEOUS SOLUTION |
| 12/03/2009 | US20090299304 Stabilized transdermal drug delivery system |
| 12/03/2009 | US20090299127 Magnet-Field Controlled Active Substance Transfer for Aerosol Therapy |
| 12/03/2009 | US20090298752 Aplidine treatment of cancers |
| 12/03/2009 | US20090297621 Microparticles For The Treatment Of Disease |
| 12/03/2009 | US20090297620 Anti-Tumor Agent |
| 12/03/2009 | US20090297619 Nanoparticulate anticonvulsant and immunosuppressive compositions |
| 12/03/2009 | US20090297618 Composition beneficial for visuognosis persistence and use thereof |
| 12/03/2009 | US20090297617 Abuse-deterrent pharmaceutical compositions of opioids and other drugs |
| 12/03/2009 | US20090297616 Wound Care Composition |
| 12/03/2009 | US20090297615 Nanoparticles, methods of making same and cell labeling using same |
| 12/03/2009 | US20090297614 Nanoparticles for providing immune responses against infectious agents |
| 12/03/2009 | US20090297613 Nanoparticles Designed for Drug Delivery |
| 12/03/2009 | US20090297612 Homogeneous, intrinsic radiopaque embolic particles |
| 12/03/2009 | US20090297611 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a tyrosine kinase inhibitor, delta opioid receptor antagonist, neurokinin receptor antagonist, or vcam inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 12/03/2009 | US20090297610 Composition and system to promote wound healing |
| 12/03/2009 | US20090297609 Method of Biomolecule Immobilization On Polymers Using Click-Type Chemistry |
| 12/03/2009 | US20090297608 Bone marrow-directing drug delivery materials and their applications |
| 12/03/2009 | US20090297607 Biomimetic polymers and uses thereof |
| 12/03/2009 | US20090297606 Gamma-lactam compounds for promoting bone growth |
| 12/03/2009 | US20090297605 Composition And Device For In Vivo Cartilage Repair |
| 12/03/2009 | US20090297604 Metal oxide hydrogels and hydrosols, their preparation and use |
| 12/03/2009 | US20090297603 Interspinous dynamic stabilization system with anisotropic hydrogels |
| 12/03/2009 | US20090297602 Modified Release Loxoprofen Compositions |
| 12/03/2009 | US20090297601 Dosage form time-lagged of drugs for the therapy of insomnia |
| 12/03/2009 | US20090297600 Novel pharmaceutical formulation containing a biguanide and an angiotensin antagonist |
| 12/03/2009 | US20090297599 Pharmaceutical compositions containing rosuvastatin calcium |
| 12/03/2009 | US20090297598 Therapeutic combination |
| 12/03/2009 | US20090297597 Modified Release Ticlopidine Compositions |
| 12/03/2009 | US20090297596 Nanoparticulate and Controlled Release Compositions Comprising a Platelet Aggregation Inhibitor |
| 12/03/2009 | US20090297595 Method For Producing A Cross-Linked Substance, Especially In The Form Of A Microcapsule Or Layer |
| 12/03/2009 | US20090297594 Oral Pharmaceutical Dosage Forms Comprising a Proton Pump Inhibitor and a NSAID |
| 12/03/2009 | US20090297593 Use of Liposomes in a Carrier Comprising a Continuous Hydrophobic Phase as a Vehicle for Cancer Treatment |
| 12/03/2009 | US20090297592 Lipid Vesicle Composition |
| 12/03/2009 | US20090297591 Compositions And Methods For The Transdermal Delivery Of Pharmaceutical Compounds |
| 12/03/2009 | US20090297590 Ketotifen transdermal drug delivery systems and methods for treating ophthalmic disease |
| 12/03/2009 | US20090297589 Method of treating burns using Avermectin compound |
| 12/03/2009 | US20090297587 Hydrogel wound dressing and its method of preparation |
| 12/03/2009 | US20090297586 Tissue Products Having A Cooling Sensation When Contacted With Skin |
| 12/03/2009 | US20090297585 pH Modulated Films for Delivery of Actives |
| 12/03/2009 | US20090297584 Biosoluble coating with linear over time mass loss |
| 12/03/2009 | US20090297583 for controlled release of bioactive agents such as drugs or biodrugs from e.g. a stent; polymeric matrix comprises an agent and a polyamideester having a design that was preselected to provide a predetermined release rate of the combination of agents from the medical article |
| 12/03/2009 | US20090297582 Vascular occlusion devices and methods |
| 12/03/2009 | US20090297580 Spinal nucleus pulposus implant |
| 12/03/2009 | US20090297579 Control of Cells and Cell Multipotentiality in Three Dimensional Matrices |
| 12/03/2009 | US20090297577 Local Delivery of Apolipoproteins and Their Derivatives |
| 12/03/2009 | US20090297576 Local Delivery of PAR-1 Antagonists to Treat Vascular Complications |
| 12/03/2009 | US20090297574 Flexable spirally-rolled polymer tube for monitoring and treatment of brain injuries |
| 12/03/2009 | US20090297573 Identifying and Modulating Molecular Pathways that Mediate Nervous System Plasticity |
| 12/03/2009 | US20090297567 Method For Ultrasound Triggered Drug Delivery Using Hollow Microbubbles With Controlled Fragility |
| 12/03/2009 | US20090297566 Oxygen-impervious packaging with optional oxygen scavenger, stabilized thyroid hormone compositions and methods for storing thyroid hormone pharmaceutical compositions |
| 12/03/2009 | US20090297565 Method and device for producing very fine particles and coating such particles |
| 12/03/2009 | US20090297508 Compositions and methods for treating hemostasis disorders associated with clec-2 signal transduction |
| 12/03/2009 | US20090297457 Preparation Of Suspension Aerosol Formulations |
| 12/03/2009 | US20090297448 Quantum Dot Barcode Structures and Uses Thereof |
| 12/03/2009 | DE202008015620U1 Phosphatbinder Phosphate binders |
| 12/03/2009 | DE20122900U1 Ubichinon Konzentrat Ubiquinone concentrate |
| 12/03/2009 | CA2765190A1 Methods of treating mammals with eustachian tube dysfunctions |
| 12/03/2009 | CA2740974A1 Dosage forms for the rapid and sustained elevation of gastric ph |
| 12/03/2009 | CA2725484A1 Percutaneously absorbable preparation |
| 12/03/2009 | CA2724639A1 Compositions comprising euphorbia prostrata and process of preparation thereof |
| 12/03/2009 | CA2724502A1 Adhesive preparation containing donepezil, and package of the same |
| 12/03/2009 | CA2724194A1 Method and composition for treating ocular hypertension and glaucoma |
| 12/03/2009 | CA2722093A1 Pharmaceutical compositions comprising brivaracetam |
| 12/03/2009 | CA2721493A1 Carbidopa/levodopa gastroretentive drug delivery |
| 12/02/2009 | EP2128162A1 Novel crystal of piperacillin sodium |
| 12/02/2009 | EP2128095A1 Spherical ferrite nanoparticle and method for production thereof |
| 12/02/2009 | EP2127687A1 Composition for treatment of cartilage disease |
| 12/02/2009 | EP2127677A1 Aminoalkylmethacrylate copolymer e for maintaining solubility of poorly water-soluble drug |
| 12/02/2009 | EP2127670A1 Liposome for induction of cell-mediated immunity |
| 12/02/2009 | EP2127658A1 Therapeutic agent for meniere s disease |
| 12/02/2009 | EP2127651A1 Stabilized medicinal composition containing donepezil, method of producing the same and method for stabilization |
| 12/02/2009 | EP2127648A1 Pharmaceutical formulations of amyloid inhibiting compounds |
| 12/02/2009 | EP2127646A1 Agent for relief or prevention of xerostomia |
| 12/02/2009 | EP2127644A1 Gel composition for medical material or hygiene material, molded article thereof and adhesive material or adhesive preparation using same |
| 12/02/2009 | EP2127643A1 Oral pellet composition with time-delayed release |
| 12/02/2009 | EP2127642A2 Microemulsions as solid dosage forms for oral administration |
| 12/02/2009 | EP2127641A1 Micronisable form of salmeterol xinafoate |
| 12/02/2009 | EP2127640A1 Azide modified proteins |
| 12/02/2009 | EP2127639A1 Corticosteroid containing liposomes for treatment of cardiovascular diseases |
| 12/02/2009 | EP2127638A1 Method and composition for treating ocular hypertension and glaucoma |
| 12/02/2009 | EP2127520A1 Gel-like sterilizing/disinfecting composition |
| 12/02/2009 | EP2125076A1 Spray administration of compositions including active agents such as peptides to the gastrointestinal tract |
| 12/02/2009 | EP2125059A1 Treatment of inflammatory and/or bacterial conditions with particles of microstructure |
| 12/02/2009 | EP2125029A2 Construction and use of transfection enhancer elements |
| 12/02/2009 | EP2124979A2 Cistus extracts |
| 12/02/2009 | EP2124973A1 Use of a masked or coated copper salt for the treatment of macular degeneration |
| 12/02/2009 | EP2124972A2 Use of a composition made of mineral nutrients and optionally acetogenic and/or butyrogenic bacteria in order to avoid or reduce the formation of gas in the large intestine of a mammal and the resulting abdominal problems |
| 12/02/2009 | EP2124961A2 Novel composition based on cholest-4-ene-3-one oxime |
| 12/02/2009 | EP2124959A1 Pharmaceutical composition |
| 12/02/2009 | EP2124950A1 Treatment of pain with naloxone |
| 12/02/2009 | EP2124931A1 Pharmaceutical compositions comprising nebivolol or a nebivolol analogue |
| 12/02/2009 | EP2124929A1 A two-component taxane containing pharmaceutical composition |
| 12/02/2009 | EP2124907A2 Transdermal patch and method for delivery of vitamin b12 |